Prelude Therapeutics reported cash from operations of -$15.57M and free cash flow of -$15.60M for the quarter ended Jun 2026, up 40.3% year over year. This cash flow statement covers 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||||||||||||||||
| Net Income | -30.84M | -33.01M | -30.29M | -29.46M | -30.41M | -33.38M | -29.11M | -32.40M | -33.38M | -37.38M | -34.34M | -37.16M | -34.38M | -33.83M | -34.61M | -32.19M | -20.42M | -17.35M | -14.18M | -15.45M | ||||||||
| Share-based CompensationStock Comp. | 8.09M | 5.78M | 8.54M | 8.92M | 9.20M | 5.84M | 11.87M | 12.08M | 12.13M | 5.91M | 14.74M | 15.18M | 15.04M | 3.77M | 16.64M | 16.48M | 15.50M | 1.84M | 17.69M | 18.21M | ||||||||
| Cash from OperationsCash from Ops. | -21.77M | -25.70M | -21.89M | -18.47M | -20.44M | -22.93M | -30.13M | -27.67M | -25.68M | -23.58M | -31.79M | -23.06M | -27.30M | -20.74M | -34.23M | -26.07M | -19.11M | 23.12M | -21.68M | -15.57M | ||||||||
| Depreciation, Depletion & Amortization | ||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 0.36M | -2.29M | -0.75M | -1.04M | -0.99M | 0.18M | 0.45M | 0.43M | 1.53M | 1.07M | 1.54M | 1.33M | 0.81M | 0.95M | 0.38M | 0.38M | 0.38M | 0.38M | 0.39M | 0.39M | ||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.27M | 0.29M | 0.31M | 0.32M | 0.34M | 0.36M | 0.28M | 0.28M | 0.28M | 0.33M | 0.43M | 0.45M | 0.41M | 0.49M | 0.43M | 0.43M | 0.42M | 0.42M | 0.39M | 0.35M | ||||||||
| Change in Working Capital | ||||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | 4.51M | -3.93M | 0.00M | -0.84M | 3.73M | -3.24M | 0.37M | -1.71M | -0.47M | -0.47M | 0.63M | 1.08M | -0.21M | 1.81M | -1.91M | -0.85M | -2.43M | 1.27M | -1.88M | -0.15M | ||||||||
| Change in Accured ExpensesChange Accured Exp. | 0.46M | 2.86M | -0.40M | 0.90M | 3.17M | 3.17M | -1.90M | -2.59M | 2.62M | 4.39M | -5.69M | 1.23M | 2.09M | 1.57M | -3.97M | 1.87M | -0.37M | -0.52M | -6.60M | 1.92M | ||||||||
| Investing Activities | ||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 0.66M | 0.30M | 0.95M | 0.76M | 0.92M | 0.39M | 0.81M | 0.98M | 0.59M | 1.13M | 0.29M | 0.36M | 0.06M | 0.05M | 0.05M | 0.02M | 0.03M | |||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 42.50M | 45.08M | 81.36M | 35.00M | 26.00M | 46.50M | 49.75M | 68.25M | 37.00M | 34.36M | 42.79M | 29.50M | 71.70M | 36.20M | 40.09M | 6.40M | 8.50M | 24.46M | ||||||||||
| Cash from Investing ActivitiesCash from Investing | -260.63M | -1.80M | 0.15M | 58.58M | 21.61M | 1.35M | 18.00M | -75.43M | 15.04M | 7.74M | 31.22M | 26.12M | 10.73M | 22.12M | 62.19M | 11.52M | 40.09M | -60.34M | 8.50M | -65.50M | ||||||||
| Financing Activities | ||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 0.71M | 1.99M | 0.15M | 0.15M | 0.06M | 0.07M | 0.03M | 0.32M | 0.29M | 0.00M | 0.25M | 0.12M | 0.09M | 0.06M | 0.03M | 0.09M | ||||||||||||
| Cash from Financing ActivitiesCash from Financing | 0.71M | 1.95M | 41.55M | -41.04M | 0.15M | 0.15M | -0.27M | 111.34M | 0.09M | 25.24M | -0.01M | 0.06M | -0.13M | -0.03M | -0.16M | 0.04M | -0.01M | 24.94M | -0.31M | 85.82M | ||||||||
| Change in Capital Stock | ||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 2.60M | 1.65M | 3.88M | 2.69M | 3.24M | 3.07M | 3.92M | 3.33M | 3.79M | 3.57M | ||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | ||||||||||||||||||||||||||||
| Additional items | ||||||||||||||||||||||||||||
| Change in Cash | -281.69M | -25.55M | 19.81M | -0.93M | 1.32M | -21.42M | -12.40M | 8.24M | -10.55M | 9.39M | -0.58M | 3.12M | -16.69M | 1.34M | 27.80M | -14.52M | 20.97M | -12.28M | -13.50M | 4.74M | ||||||||
| Free Cash FlowFCF | -22.43M | -26.00M | -22.85M | -19.23M | -21.36M | -23.32M | -30.94M | -28.65M | -26.27M | -24.71M | -32.08M | -23.42M | -27.36M | -20.80M | -34.28M | -26.09M | -19.11M | 23.12M | -21.68M | -15.60M | ||||||||
| Net Cash FlowNCF | -281.69M | -25.55M | 19.81M | -0.93M | 1.32M | -21.42M | -12.40M | 8.24M | -10.55M | 9.39M | -0.58M | 3.12M | -16.69M | 1.34M | 27.80M | -14.52M | 20.97M | -12.28M | -13.50M | 4.74M |